Photopharmics Raises $2.0M

Highland, Utah-based Photopharmics, a firm developing treatments for Parkinson's disease, has quitely raised $2.0M in a funding round, part of a $3.11M round, according to a recent filing by the firm. Source of the funding was not disclosed. The company says on its website that its founders founded Apollo Light Systems, a developer of specialized therapy for circadian related disorders such as sleep and mood disorders. More information »